These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24741114)

  • 1. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.
    Liu Y; Chen J; Sethi A; Li QK; Chen L; Collins B; Gillet LC; Wollscheid B; Zhang H; Aebersold R
    Mol Cell Proteomics; 2014 Jul; 13(7):1753-68. PubMed ID: 24741114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors.
    Li QK; Chen J; Hu Y; Höti N; Lih TM; Thomas SN; Chen L; Roy S; Meeker A; Shah P; Chen L; Bova GS; Zhang B; Zhang H
    Sci Rep; 2021 Sep; 11(1):18936. PubMed ID: 34556748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proteome of Primary Prostate Cancer.
    Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
    Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.
    Bedolla RG; Shah DP; Huang SB; Reddick RL; Ghosh R; Kumar AP
    Mol Carcinog; 2019 Jun; 58(6):854-861. PubMed ID: 30859654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential.
    Ruela-de-Sousa RR; Hoekstra E; Hoogland AM; Souza Queiroz KC; Peppelenbosch MP; Stubbs AP; Pelizzaro-Rocha K; van Leenders GJLH; Jenster G; Aoyama H; Ferreira CV; Fuhler GM
    Eur Urol; 2016 Apr; 69(4):710-719. PubMed ID: 26159288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
    Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
    Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.
    Hayashi T; Oue N; Sakamoto N; Anami K; Oo HZ; Sentani K; Ohara S; Teishima J; Matsubara A; Yasui W
    Pathobiology; 2011; 78(5):277-84. PubMed ID: 21849809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
    Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
    Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.
    Cazares LH; Troyer D; Mendrinos S; Lance RA; Nyalwidhe JO; Beydoun HA; Clements MA; Drake RR; Semmes OJ
    Clin Cancer Res; 2009 Sep; 15(17):5541-51. PubMed ID: 19690195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer.
    Tian Y; Bova GS; Zhang H
    Anal Chem; 2011 Sep; 83(18):7013-9. PubMed ID: 21780747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
    Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z
    Oncol Rep; 2017 Jun; 37(6):3209-3218. PubMed ID: 28440432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
    Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
    Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
    Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
    Kamoun A; Cancel-Tassin G; Fromont G; Elarouci N; Armenoult L; Ayadi M; Irani J; Leroy X; Villers A; Fournier G; Doucet L; Boyault S; Brureau L; Multigner L; Diedhiou A; Roupret M; Compérat E; Blanchet P; de Reyniès A; Cussenot O
    Ann Oncol; 2018 Aug; 29(8):1814-1821. PubMed ID: 29945238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
    Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis.
    Gao Y; Ha YS; Kwon TG; Cho YC; Lee S; Lee JN
    Cancer Genomics Proteomics; 2020; 17(5):543-553. PubMed ID: 32859632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
    Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
    Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.